Revisiting De Novo drug design : receptor based pharmacophore screening

Revisiting De Novo drug design : receptor based pharmacophore screening

De novo drug design methods such as receptor or protein based pharmacophore modeling present a unique opportunity to generate novel ligands by employing the potential binding sites even when no explicit ligand information is known for a particular target. Recent developments in molecular modeling pr...

Saved in:

書目詳細資料
Main Authors:	Yoon, Ho Sup, Amaravadhi, Harikishore, Baek, Kwanghee
其他作者:	School of Biological Sciences
格式:	Article
語言:	English
出版:	2015
主題:	DRNTU::Science::Medicine
在線閱讀:	https://hdl.handle.net/10356/106721 http://hdl.handle.net/10220/25112
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!

相似書籍

Combination of pharmacophore hypothesis and molecular docking to identify novel inhibitors of HCV NS5B polymerase
由: Harikishore, Amaravadhi, et al.
出版: (2015)

Pharmacophore-guided Virtual Screening to Identify New β3-adrenergic Receptor Agonists
由: Ujiantari, Navista Sri Octa, et al.
出版: (2022)

Solution structure of FK506-binding protein 12 from Aedes aegypti
由: Chakraborty, Goutam, et al.
出版: (2013)

The de novo selection of drug-resistant malaria parasites
由: N. J. White, et al.
出版: (2018)

De novo design of potent antimicrobial peptides
由: Frecer, V., et al.
出版: (2014)

Discovery of a small-molecule inhibitor of STAT3 by ligand-based pharmacophore screening
由: Leung, Ka-Ho, et al.
出版: (2016)

Pharmacophore-Based Virtual Screening and Experimental Validation of Pyrazolone-Derived Inhibitors toward Janus Kinases
由: Sanachai K.
出版: (2023)

De novo-designed β-sheet heme proteins
由: D'Souza, Areetha, et al.
出版: (2021)

PHARMACOPHORE-BASED VIRTUAL SCREENING FOR IDENTIFYING POTENTIAL COMPOUNDS AS INHIBITOR OF UROKINASE PLASMINOGEN ACTIVATOR (uPA)
由: Arfan

Pharmacophoric models of sodium channel antagonists
由: POON THONG YUEN
出版: (2010)

Histopathology of de novo autoimmune hepatitis
由: Ananya Pongpaibul, et al.
出版: (2018)

Towards the design of 3-aminopyrazole pharmacophore of pyrazolopyridine derivatives as novel antioxidants
由: Apilak Worachartcheewan, et al.
出版: (2018)

Mapping antimalarial pharmacophores as a useful tool for the rapid discovery of drugs effective in vivo: Design, construction, characterization, and pharmacology of metaquine
由: Michael J. Dascombe, et al.
出版: (2018)

DE NOVO DESIGN OF ANTIMICROBIAL PEPTIDES FOR APPLICATION AS ANTI-INFECTIVE AGENTS
由: JASMEET SINGH KHARA
出版: (2017)

De Novo Design and Experimental Characterization of Ultrashort Self-Associating Peptides
由: Smadbeck J., et al.
出版: (2019)

A novel de novo androgen receptor nonsense mutation in a sex-reversed 46,XY infant
由: Poon, KS, et al.
出版: (2021)

Pharmacophore modeling for the identification of small-molecule inhibitors of TACE
由: Liu, Li-Juan, et al.
出版: (2016)

Structural optimization and de novo design of dengue virus entry inhibitory peptides
由: Costin J.M., et al.
出版: (2019)

SWPepNovo : an efficient de novo peptide sequencing tool for large-scale MS/MS spectra analysis
由: Li, Chuang, et al.
出版: (2020)

Spectrum-based de novo repeat detection in genomic sequences
由: Do, H.H., et al.
出版: (2013)

Nicotinic acid and derivatives as multifunctional pharmacophores for medical applications
由: Nujarin Sinthupoom, et al.
出版: (2018)

The scope of ‘de novo’ review of an arbitral tribunal’s jurisdiction
由: CHAN, Darius
出版: (2015)

Entry Strategy and Survival of De Novo New Ventures
由: FAN, Terence Ping Ching
出版: (2006)

DE NOVO ORGANOGENESISI AND TISSUE REPAIR IN THE ARABIDOPSIS ROOT
由: AJAY DEVENDRAN
出版: (2018)

Pharmacophore elucidation for a new series of 2-aryl-pyrazolo-triazolo- pyrimidines as potent human A3 adenosine receptor antagonists
由: Cheong, S.L., et al.
出版: (2014)

Buckyball-based spherical display of crown ethers for de novo custom design of ion transport selectivity
由: Li, Ning, et al.
出版: (2023)

Accelerated engineering of ELP-based materials through hybrid biomimetic-de novo predictive molecular design
由: Laakko, Timo, et al.
出版: (2024)

Rational and efficient geometric definition of pharmacophores is essential for the patent process
由: Georges Alexandre Guérin, et al.
出版: (2018)

Novel targets and inhibitors of the Mycobacterium tuberculosis cytochrome bd oxidase to foster anti-tuberculosis drug discovery
由: Harikishore, Amaravadhi, et al.
出版: (2023)

Antiviral activity against Middle East Respiratory Syndrome coronavirus by Montelukast, an anti-asthma drug
由: Gan, Hanjie Jonathan, et al.
出版: (2022)

Hubris, rapid capacity expansions and the competition in de novo ventures
由: FAN, Terence Ping Ching, et al.
出版: (2010)

Metabolic engineering of Saccharomyces cerevisiae for de novo production of kaempferol
由: Lyu, Xiaomei, et al.
出版: (2021)

Engineering yeast phospholipid metabolism for de novo oleoylethanolamide production
由: Yi Liu, et al.
出版: (2020)

De novo food allergy in pediatric liver transplantation recipients
由: Ratchaneewan Sinitkul, et al.
出版: (2019)

De Novo Venture Strategy: Inaugural Entry and Arch-Incumbency
由: FAN, Terence Ping Ching
出版: (2009)

Big Expansions, Monopoly Markets and the Survival of De Novo Entrants
由: FAN, Terence Ping Ching
出版: (2009)

High-resolution crystal structure of FKBP12 from Aedes aegypti
由: Rajan, Sreekanth, et al.
出版: (2013)

Increasing the odds of drug hit identification by screening against receptor homologs?
由: Ji, Z.L., et al.
出版: (2014)

A de novo L330S point mutation in thyroid hormone receptor beta gene in a Thai female with resistance to thyroid hormone
由: Sasitorn Ditudompo, et al.
出版: (2018)

Structural and functional characterization of β-sheet heme binding peptides : de novo designed and naturally occurring
由: D'Souza, Areetha Renita
出版: (2018)